Loading...
Nu Skin Enterprises, Inc.
NUS•NYSE
Consumer Defensive
Household & Personal Products
$8.75
$-0.21(-2.34%)
Nu Skin Enterprises, Inc. (NUS) Financial Performance & Income Statement Overview
Review Nu Skin Enterprises, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-12.04%
↓ 12.04%
Operating Income Growth
-414.05%
↓ 414.05%
Net Income Growth
-1805.57%
↓ 1805.57%
Operating Cash Flow Growth
-5.81%
↓ 5.81%
Operating Margin
-1.25%
↓ 1.25%
Gross Margin
67.57%
↑ 67.57%
Net Profit Margin
-2.30%
↓ 2.30%
ROE
-5.51%
↓ 5.51%
ROIC
-1.85%
↓ 1.85%
Nu Skin Enterprises, Inc. (NUS) Income Statement & Financial Overview
Review Nu Skin Enterprises, Inc.'s (NUS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $445.55M | $430.14M | $439.08M | $417.31M |
| Cost of Revenue | $166.41M | $128.68M | $131.90M | $123.24M |
| Gross Profit | $279.15M | $301.46M | $307.18M | $294.06M |
| Gross Profit Ratio | $0.63 | $0.70 | $0.70 | $0.70 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $286.35M | $283.23M | $283.38M | $278.11M |
| Operating Expenses | $332.23M | $283.23M | $283.38M | $278.11M |
| Total Costs & Expenses | $452.76M | $411.91M | $415.29M | $401.35M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.86M | $6.50M | $6.72M | $7.33M |
| Depreciation & Amortization | $16.45M | $17.32M | $17.60M | $18.44M |
| EBITDA | -$35.49M | $37.12M | -$107.33M | $34.39M |
| EBITDA Ratio | -$0.08 | $0.09 | -$0.24 | $0.08 |
| Operating Income | -$53.08M | $18.23M | $23.79M | $15.96M |
| Operating Income Ratio | -$0.12 | $0.04 | $0.05 | $0.04 |
| Other Income/Expenses (Net) | -$4.72M | -$4.93M | -$6.09M | -$7.72M |
| Income Before Tax | -$57.80M | $13.30M | -$131.65M | $1.10M |
| Income Before Tax Ratio | -$0.13 | $0.03 | -$0.30 | $0.003 |
| Income Tax Expense | -$21.70M | $5.00M | -$13.39M | $1.63M |
| Net Income | -$36.10M | $8.30M | -$118.26M | -$533000.00 |
| Net Income Ratio | -$0.08 | $0.02 | -$0.27 | -$0.001 |
| EPS | -$0.73 | $0.17 | -$2.38 | -$0.01 |
| Diluted EPS | -$0.73 | $0.17 | -$2.38 | -$0.01 |
| Weighted Avg Shares Outstanding | $49.71M | $49.71M | $49.69M | $49.54M |
| Weighted Avg Shares Outstanding (Diluted) | $49.71M | $49.73M | $49.69M | $49.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan